# Comparison of Human Insulin Produced by the Current Process and the NN729 Process in Type 1 Diabetes

> **NCT00569400** · PHASE3 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 241 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** human insulin

## Key facts

- **NCT ID:** NCT00569400
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-05-01
- **Primary completion:** 2004-01-19
- **Final completion:** 2004-01-19
- **Target enrollment:** 241 (ACTUAL)
- **Last updated:** 2017-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00569400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00569400, "Comparison of Human Insulin Produced by the Current Process and the NN729 Process in Type 1 Diabetes". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00569400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*